ReviewFrontiers in oncology2022

Choosing the optimal immunotherapeutic strategies for non-small cell lung cancer based on clinical factors.

Natsuki Nakagawa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.